Ministry of Economy

THC and CBD pro-nano-liposphere (PNL) oral capsule – clinical study - Amnon Hoffman & Avi DombRead more >

MMJ Phytotech

Clinical development of CBD/THC oral formulations - Amnon Hoffman & Avi Domb

PHYTECS

Fluorinated cannabinoids - Raphael MechoulamRead more >

Kalytera

Novel cannabinoids as drugs for bones, pain, head injury - Raphael MechoulamRead more >

CANNABITECH

Remote sensing and sorting of cannabis flowers - Oded ShoseyovRead more >

Israel Science Foundation

TRPV1 activation by endogenous vanilloids: cellular regulation and molecular mechanism - Avi Priel

Role of the Peripheral Endocannabinoid System in Leptin Resistance and Obesity - Joseph Tam

Deciphering the Crosstalk between CB1 and GLUT2 in the Development of Diabetic Nephropathy - Joseph Tam

Stretching the Model of TRPV1 Activation - Dmitry Tsvelikhovsky

European Research Council

From Peripheral to Cell- and Organelle-Targeted Medicine: The 3rd Generation of Cannabinoid-1 Receptor Antagonists for the Treatment of Chronic Kidney Disease - Joseph TamRead more >

Multidisciplinary Center For Cannabinoid Research

Studying the anti-angiogenic and anti-cancer activity of cannabinoid receptor 2 (CB2) agonists - Ofra Benny

Effect of a cannabis extract on acute radicular pain and on analgesics requirement: a double-blinded, randomized, 24 hours follow-up study - Elyad Davidson

The Effects of CBD on Traumatic Brain Injury - Rami Yaka & Oren Ostresetzer

Cannabinoid Innovation

The therapeutic benefit of cannabis for the treatment of asthma - Raphael Mechoulam & Francesca Levi-Schaffer

Testing the therapeutic effect of phytocannabinoids for nonalcoholic fatty liver disease - Joseph Tam

Integra Holdings

Towards novel migraine drugs: activation of the pain receptor TRPA1 by cannabinoids - Avi Priel & Masha Niv

Discovery and Experimental Confirmation of Novel (Dual-Targeted) Peripherally Restricted CB1 Receptor Antagonists - Joseph Tam, Amiram Goldblum & Yuval Tabach